The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort.

RATIONALE Understanding normal lung development and aging in health and disease, both in men and in women, is essential to interpreting any therapeutic intervention. OBJECTIVES We aimed to describe lung function changes in healthy never-smoking males and females, from adolescence to old age, and to determine the effects of smoking and those derived from quitting. METHODS Prospective cohort study within all participants of the Framingham Offspring cohort who had two or more valid spirometry measurements during follow-up (n = 4,391; age range at baseline 13 to 71 yr), with a median follow-up time of 23 years. MEASUREMENTS AND MAIN RESULTS To best fit the curves describing FEV(1) changes with age to raw data, we used a generalized additive model with smooth terms and incorporating the subject-specific (longitudinal) random effects. We found that: (1) healthy never-smoker females achieve full lung growth earlier than males, and their rate of decline with age was slightly, but not significantly, lower; (2) smoking increases the rate of lung function decline, both in males and in females; (3) there is a range of susceptibility to the effects of smoking. The presence of respiratory symptoms at baseline and/or a respiratory diagnosis during follow-up appears to identify a group of susceptible smokers; and (4) quitting smoking has a beneficial effect at any age, but it is more pronounced in earlier quitters. CONCLUSIONS Lung function changes from adolescence to old age differ in males and females, smoking has similar deleterious effects in both sexes, and quitting earlier is better.

[1]  J. Hankinson,et al.  Cross-sectional and longitudinal spirometry in children and adolescents: interpretative strategies. , 2008, American journal of respiratory and critical care medicine.

[2]  S. Stanojevic,et al.  Reference ranges for spirometry across all ages: a new approach. , 2008, American journal of respiratory and critical care medicine.

[3]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[4]  Majid Ezzati,et al.  Global Burden of Disease 2005: call for collaborators , 2007, The Lancet.

[5]  D. Jarvis,et al.  Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. , 2007, American journal of respiratory and critical care medicine.

[6]  S. Holgate Priorities for respiratory research in the UK , 2006, Thorax.

[7]  D. Mannino,et al.  Lung function decline and outcomes in an adult population. , 2006, American journal of respiratory and critical care medicine.

[8]  G. Davey Smith,et al.  The natural history of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[9]  S. Wood Generalized Additive Models: An Introduction with R , 2006 .

[10]  K. R. Chapman,et al.  Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[11]  D. Mannino,et al.  Lung function decline and outcomes in an elderly population , 2005, Thorax.

[12]  U. Ackermann-Liebrich,et al.  Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study , 2005, Respiratory research.

[13]  J. Schouten,et al.  Determinants of maximally attained level of pulmonary function. , 2004, American journal of respiratory and critical care medicine.

[14]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[15]  John E Connett,et al.  Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.

[16]  W. Bailey,et al.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.

[17]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[18]  N. Anthonisen,et al.  Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. , 1998, Journal of clinical epidemiology.

[19]  D. Postma,et al.  Decline of FEV1 by age and smoking status: facts, figures, and fallacies. , 1997, Thorax.

[20]  J. Vestbo,et al.  Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study , 2002 .

[21]  D. Dockery,et al.  Effects of cigarette smoking on lung function in adolescent boys and girls. , 1996, The New England journal of medicine.

[22]  P. Enright,et al.  Lung function development in young adults: is there a plateau phase? , 1995, The European respiratory journal.

[23]  R. Tibshirani,et al.  Generalized additive models for medical research , 1995, Statistical methods in medical research.

[24]  J. Schouten,et al.  Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. , 1994, The European respiratory journal.

[25]  G. Borsboom,et al.  Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. , 1994, American journal of respiratory and critical care medicine.

[26]  X. Xu,et al.  Gender difference in smoking effects on adult pulmonary function. , 1994, The European respiratory journal.

[27]  M. Lebowitz,et al.  On the temporal relationships between lung function and somatic growth. , 1989, The American review of respiratory disease.

[28]  F. Speizer,et al.  The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. , 1988, The American review of respiratory disease.

[29]  M. Lebowitz,et al.  Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. , 1987, The American review of respiratory disease.

[30]  W. Kannel,et al.  Influence of cigarette smoking on lung function at baseline and at follow-up in 14 years: the Framingham Study. , 1987, Journal of chronic diseases.

[31]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[32]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[33]  G. Little,et al.  The natural history of chronic bronchitis and emphysema , 1979 .